Page 383 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 383

Chapter 26  Biology of Erythropoiesis, Erythroid Differentiation, and Maturation  319


            are mainly satisfied through a greatly amplified late erythroid pool   selective destruction at a given stage of maturation (of red cells only or
            and with a minimum distortion in the differentiation sequence. 155,621    of both erythroblasts and red cells) can be observed depending on the
            The fact that the kinetics of erythroid differentiation/maturation are   type of antibody produced and the density of its antigen on maturing
            different in acute versus chronic marrow regeneration is supported   erythroid cells. Qualitative aberrations in the response of erythroid
            by differing qualitative changes in the newly formed red cells. An   progenitors to cytokines or EPO may underlie the abnormalities of
                                                                                                                  389
            increase in i antigen and HbF expression as well as an increase in cells   congenital  erythroid  hypoplasia  (Diamond-Blackfan  syndrome).
            with higher mean corpuscular volumes is seen with an acute response,   Analogous qualitative or functional defects can be observed in neo-
            whereas these alterations are minimal or less pronounced with chronic   plastic  erythropoiesis,  because  erythroid  progenitors  from  patients
            responses. 155,622  When severe anemia persists from birth onward, ery-  with polycythemia vera and other myeloproliferative neoplasms have
                                                         621
            throid production can increase up to 10-fold above baseline.  This   altered sensitivities to EPO. 630
            is possible not only because of maximally expanded erythropoietic   Detailed  knowledge  of  the  structural  and  functional  properties
            pools but also because the sites of active erythropoiesis may extend   of  erythroid  cells  throughout  their  differentiation  may  provide
            to include those that support red cell differentiation during fetal life.   significant insights into the pathogenesis of hematopoietic disorders
            Thus  although  the  marrow  space  in  axial  bones  (vertebrae,  pelvis,   affecting the red cell lineage.
            ribs, sternum, clavicles) is sufficient for normal erythropoiesis or for
            response to moderate anemia, the femur, humerus, spleen and/or liver,
            and (rarely) thymus may support red cell production in children with   SUGGESTED READINGS
            congenital  hemolytic  anemia  (e.g.,  thalassemia  major).  Expanded
            erythropoiesis may lead to skeletal deformities, hepatosplenomegaly,   Abdel-Wahab O, Levine R: The spliceosome as an indicted conspirator in
            or erythropoiesis in the soft tissues adjacent to bone.  myeloid malignancies. Cancer Cell 20:420, 2011.
              Quantitative  assessments  of  changes  in  erythroid  progenitor   Agarwal N, Gordeuk RV, Prchal JT: Genetic mechanisms underlying regula-
            cell  pools  in  response  to  EPO  stimulation  can  be  made  through   tion of hemoglobin mass. Adv Exp Med Biol 618:195, 2007.
            cultures  of  bone  marrow  cells.  Despite  sampling  errors,  erythroid   Andrews NC: Closing the iron gate. N Engl J Med 366:376, 2012.
            cultures can provide rough estimates of relative progenitor abundance   Anstee  DJ:  The  relationship  between  blood  groups  and  disease.  Blood
            within  an  aspirated  marrow  specimen  and  have  shown  consistent   115:4635, 2010.
            increases in the frequency of CFU-E in proportion to the level of   Baron MH, Isern J, Fraser ST: The embryonic origins of erythropoiesis in
            EPO stimulation. 623,624  Conversely, with increases in the hematocrit   mammals. Blood 119:4828, 2012.
            or  in  polycythemic  animals,  a  decrease  in  CFU-E  frequency  has   Bauer DE, Kamran SC, Orkin SH: Reawakening fetal hemoglobin: prospects
            been observed. 625,626  In contrast to CFU-E, the incidence of BFU-E   for new therapies for the beta-globin disorders. Blood 120:2945, 2012.
            was found to fluctuate less with either acute or chronic expansion of   Bianco P: Bone and the hematopoietic niche: a tale of two stem cells. Blood
            erythropoiesis, probably because a few BFU-E can generate several   117:5281, 2011.
            thousand cells. Furthermore, BFU-E can increase their fraction in   Bieker JJ: Putting a finger on the switch. Nat Genet 42:733, 2010.
            cycle and thus increase the number of differentiated progeny without   Bissels U, Bosio A, Wagner W: MicroRNAs are shaping the hematopoietic
            a significant change in their total numbers. Most BFU-E detectable in   landscape. Haematologica 97:160, 2012.
            marrow or blood erythroid cultures probably represent a reservoir of   Bowie MB, Kent DG, Copley MR, et al: Steel factor responsiveness regulates
            progenitors not normally participating in day-to-day erythropoiesis.   the high self-renewal phenotype of fetal hematopoietic stem cells. Blood
            The parameters needed to maintain a healthy or appropriate BFU-E   109:5043, 2007.
            pool in hematopoiesis are not defined. That hematopoietic expansion   Bowman TV, Trompouki E, Zon LI: Linking hematopoietic regeneration to
            is curtailed in mice with steel mutations and anemia develops in mice   developmental signaling pathways: a story of BMP and Wnt. Cell Cycle
                                     627
            treated with anti-C-KIT antibody  suggests that adequate levels of   11:424, 2012.
            normal KL may be crucial for early erythropoietic expansion. 205  Bresnick EH, Lee HY, Fujiwara T, et al: GATA switches as developmental
              The  rate  of  red  cell  production  can  also  be  accurately  evalu-  drivers. J Biol Chem 285:31087, 2010.
            ated  by  ferrokinetic  studies  (i.e.,  study  of  iron  incorporation  into   Bunn HF: New agents that stimulate erythropoiesis. Blood 109:868, 2007.
            developing  red  cells).  In  addition,  a  marrow  scan,  typically  with   Byon JC, Papayannopoulou T: MicroRNAs: allies or foes in erythropoiesis?
            technetium  Tc  99m,  can  document  the  extent  of  active  erythro-  J Cell Physiol 227:7, 2012.
            poiesis. However, these approaches are seldom necessary in clinical   Choesmel V, Bacqueville D, Rouquette J, et al: Impaired ribosome biogenesis
            practice because estimates of erythropoiesis can be obtained from the   in Diamond-Blackfan anemia. Blood 109:1275, 2007.
                         621
            reticulocyte index.  First, the observed percentage of reticulocytes is   Crispino JD, Weiss MJ: Erythro-megakaryocytic transcription factors associ-
            normalized to the hematocrit to calculate the total marrow output of   ated with hereditary anemia. Blood 123:3080, 2014.
            reticulocytes. Alternatively, the absolute number of reticulocytes per   Di  Baldassarre  A,  Di  Rico  M,  Di  Noia  A,  et al:  Protein  kinase  Calpha
            microliter can be counted directly using fluorescent RNA labeling.   is  differentially  activated  during  neonatal  and  adult  erythropoiesis  and
            However, because younger reticulocytes are prematurely released into   favors expression of a reporter gene under the control of the (A)gamma
            the circulation under conditions of acute need, the total number of   globin-promoter  in  cellular  models  of  hemoglobin  switching.  J  Cell
            reticulocytes  overestimates  the  true  level  of  red  cell  production  as   Biochem 101:411, 2007.
                               621
            measured by iron kinetics.  Therefore a second correction is made   Dore LC, Crispino JD: Transcription factor networks in erythroid cell and
            to account for the maturation of early circulating reticulocytes, or   megakaryocyte development. Blood 118:231, 2011.
            “shift” cells (polychromatophilic red cells), when present in the blood   Fabriek  BO,  Polfliet  MM,  Vloet  RP,  et al:  The  macrophage  CD163
            smear. The resulting reticulocyte index gives excellent estimates of   surface glycoprotein is an erythroblast adhesion receptor. Blood 109:5223,
            effective red cell production.                          2007.
              Although the presence, density, or both of EPORs on developing   Flygare J, Aspesi A, Bailey JC, et al: Human RPS19, the gene mutated in
            erythroid  cells  determines  the  responses  to  EPO,  other  properties   Diamond-Blackfan anemia, encodes a ribosomal protein required for the
            (e.g.,  surface  antigens  on  BFU-E  versus  CFU-E  versus  end-stage   maturation of 40S ribosomal subunits. Blood 109:980, 2007.
            red cells) may provide the basis for selective suppression of CFU-E   Fraser  ST,  Isern  J,  Baron  MH:  Maturation  and  enucleation  of  primitive
            versus  BFU-E  or  selective  immune  destruction  of  red  cells  versus   erythroblasts during mouse embryogenesis is accompanied by changes in
            erythroblasts. For example, suppression of CFU-E or erythroblasts   cell-surface antigen expression. Blood 109:343, 2007.
                                          628
            can occur in acquired pure red cell aplasia  or B19 parvovirus infec-  Ganz T, Nemeth E: Iron metabolism: interactions with normal and disordered
               629
            tion,  respectively, whereas BFU-E in both these conditions remain   erythropoiesis. Cold Spring Harb Perspect Med 2:a011668, 2012.
            largely unperturbed. Thus the boundary from BFU-E to CFU-E and   Ghinassi  B,  Sanchez  M,  Martelli  F,  et al:  The  hypomorphic  Gata1low
            erythroblast may be biologically important for the pathophysiology   mutation alters the proliferation/differentiation potential of the common
            of these disease states. Furthermore, in acquired hemolytic anemia,   megakaryocytic-erythroid progenitor. Blood 109:1460, 2007.
   378   379   380   381   382   383   384   385   386   387   388